A recent real-world data study published in the Journal of Dermatological Treatment finds that patients with psoriasis change up their biologic therapeutics. Claims data from nearly 8,000 patients taken revealed that, on average, 14.4% of patients changed biologics within 12 months of the study’s two year period, while over a quarter swapped by 24 months.
According to Gianna Melillo, “It’s also been previously shown that female gender, age under 65 and atherosclerotic conditions have been linked with lower adherence. The management of psoriasis is associated with a high economic burden due to the disease’s complexities. Approximately half of patients experience disruptions in therapy, like switching biologic therapy or changes in dosing.”
To read more, click here.
(Source: AJMC, May 20th, 2023)